本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

18.82
-0.0500-0.26%
盤前19.040.2200+1.17%04:20 EDT
成交量:134.17萬
成交額:2,533.94萬
市值:24.06億
市盈率:109.16
高:19.32
開:18.94
低:18.74
收:18.87
52周最高:30.48
52周最低:16.10
股本:1.28億
流通股本:7,811.99萬
量比:0.78
換手率:1.72%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
淨資產收益率:7.48%
總資產收益率:3.53%
市淨率:6.50
市盈率(LYR):109.16

資料載入中...

2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities